Skip to main content
Home
  • Solutions
    Clinical solutions
    Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Manufacturing & Pharmacy Services Medical Imaging Site & Patient Solutions Strategic Solutions
    Consulting & Commercial
    Asset Development Consulting Commercial Positioning Language Services Outcome Measures Real World Solutions Regulatory Affairs
    meeting
    Case studies

    Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.
    Innovative research tools showcase
    Technologies

    Technology solutions from early phase through to post-marketing.
  • Sectors
    Sectors

    ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

    Read more
    Biotech Government and Public Health Medical Device Pharmaceuticals
    Biotechnology services navigation panel
    Biotech

    Developing transformative therapies requires a flexible approach.
    Employee engagement program overview
    ICON and You

    Partners making a difference.
  • Therapeutics
    Therapeutics
    Cardiovascular Central Nervous System Critical Care Endocrine & Metabolic Disorders Hepatology Infectious Diseases Internal Medicine & Immunology Oncology
    Cross-therapeutics
    Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health
    Oncology whitepaper web assets
    Oncology

    An early pioneer in oncology CGT, ICON has contributed to over 60 FDA/EMA approved therapies in the last 5 years.
    Biological research visual element
    Therapeutics insights

    ICON's therapeutic experts contribute regularly to industry publications on the latest medical, scientific and clinical developments.
  • Insights
    Insights
    Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel
    whitepaper
    Immunotherapy beyond cancer

    Adapting to the needs of chronic disease patient populations
    software as a medical device
    Designing the future

    Regulatory readiness for next-generation AI-enabled software as a medical device (SaMD)
    thumbnail
    From here to where?

    Plotting a course to bring APAC-developed drugs to the world
  • News & Events
    News & Events

    ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

    Read more
    Press releases In the News Mediakit Awards Events Webinars Social media hub
    banner
    ISPOR EU

    8 November 2026. Register now.
    thumbnail
    Getting COA strategy right from the start

    5 November 2026. Register now.
  • About ICON
    About ICON
    Company history ICON at a glance ICON in Asia Pacific ICON in Latin America Leadership Quality
    ICON for
    Patients Investigators Jobs & Careers Investors Suppliers
    Responsible business practice indicators
    Sustainability, charity, inclusion and belonging

    ICON Cares is our commitment to making a positive impact on our people, environment and our community.
    Modern reception area at Dublin office
    ICON at a glance

    Delivering successful outcomes across the clinical development lifecycle.
  • Careers
  • Investors
  • Contact
  • 日本語
  • 简体中文
  1. Home
  2. Contact
  3. Account Enquiry

Account Enquiry

Page tools
Share Share
Facebook

Share on Linkedin

Bluesky

Share on Bluesky

Facebook

Share on X

Facebook

Share on Facebook
Site Branding
    ICON plc
  • Contact
  • About ICON
  • Results & Reports
For Clients
  • Therapeutics
  • Solutions
  • Insights
  • Technologies
  • Office locations
ICON for
  • Patients
  • Volunteers
  • Investigators
  • Jobs & Careers
  • Investors
  • Suppliers
News & Events
  • Press releases
  • Mediakit
  • Events
  • Webinars
  • Social media hub
Socials
  • LinkedIn
  • Facebook
  • Instagram
  • YouTube

Legal Footer

  • © 2026 ICON plc
  • Disclaimer
  • Privacy & Data
  • Cookies
  • Sitemap